TD Cowen Cuts Beauty Health (NASDAQ:SKIN) Price Target to $1.50

Beauty Health (NASDAQ:SKINFree Report) had its target price cut by TD Cowen from $1.65 to $1.50 in a research report released on Monday, MarketBeat reports. They currently have a hold rating on the stock.

Other analysts have also issued research reports about the company. Jefferies Financial Group reissued a “hold” rating and issued a $1.60 target price on shares of Beauty Health in a research report on Wednesday, January 14th. Zacks Research lowered Beauty Health from a “hold” rating to a “strong sell” rating in a research report on Wednesday, January 21st. Benchmark reaffirmed a “hold” rating on shares of Beauty Health in a research note on Friday, March 13th. Finally, Canaccord Genuity Group reiterated a “hold” rating and issued a $1.50 price objective on shares of Beauty Health in a report on Friday, March 13th. One equities research analyst has rated the stock with a Buy rating, five have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Reduce” and an average price target of $2.42.

Read Our Latest Analysis on SKIN

Beauty Health Trading Up 0.9%

Shares of SKIN stock opened at $1.18 on Monday. The company has a debt-to-equity ratio of 3.94, a current ratio of 1.66 and a quick ratio of 1.40. The firm has a market cap of $150.45 million, a PE ratio of -5.90 and a beta of 1.20. The company has a 50-day moving average of $1.25 and a two-hundred day moving average of $1.50. Beauty Health has a 1-year low of $0.78 and a 1-year high of $2.69.

Beauty Health (NASDAQ:SKINGet Free Report) last released its quarterly earnings results on Thursday, March 12th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. Beauty Health had a negative net margin of 3.16% and a negative return on equity of 15.40%. The business had revenue of $82.37 million for the quarter, compared to the consensus estimate of $78.07 million. On average, analysts predict that Beauty Health will post -0.25 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Woodline Partners LP raised its holdings in Beauty Health by 255.9% during the third quarter. Woodline Partners LP now owns 5,930,027 shares of the company’s stock worth $11,801,000 after purchasing an additional 4,263,997 shares in the last quarter. Millennium Management LLC grew its position in shares of Beauty Health by 127.0% in the 4th quarter. Millennium Management LLC now owns 5,764,802 shares of the company’s stock valued at $8,013,000 after buying an additional 3,225,668 shares during the last quarter. Mirabella Financial Services LLP grew its position in shares of Beauty Health by 21.3% in the 3rd quarter. Mirabella Financial Services LLP now owns 15,596,277 shares of the company’s stock valued at $31,037,000 after buying an additional 2,734,728 shares during the last quarter. Soleus Capital Management L.P. acquired a new stake in Beauty Health during the 2nd quarter worth $1,910,000. Finally, Geode Capital Management LLC raised its stake in Beauty Health by 27.5% during the 2nd quarter. Geode Capital Management LLC now owns 2,302,784 shares of the company’s stock worth $4,399,000 after acquiring an additional 496,963 shares in the last quarter. Hedge funds and other institutional investors own 93.26% of the company’s stock.

Beauty Health Company Profile

(Get Free Report)

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.

Recommended Stories

Analyst Recommendations for Beauty Health (NASDAQ:SKIN)

Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.